The American Academy of Dermatology (AAD) meeting last week continued to provide positive news, including from US biotech ...

US biotech Regenxbio (Nasdaq: RGNX) has successfully completed the BLA submission for its mucopolysaccharidosis II (MPS II) ...

Japanese drugmaker Ono (TYO: 4528) has entered into a license agreement with USA-based Ionis Pharmaceuticals (Nasdaq: IONS) ...

Chinese pharmaceutical company Fosun Pharmaceutical Group (SHA: 600196) has agreed to sell its stake in private hospital ...

The UK government plans to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject ...

The US Food and Drug Administration (FDA) has announced its recommendations to vaccine manufacturers for the virus strains to ...

The UK has announced plans to abolish NHS England and integrate its functions into the central government, marking a ...

USA-based Azurity Pharmaceuticals says it has completed its acquisition of Covis Group from existing investors and the ...

Innovent Biologics (HKEX: 01801) has gained approval in China for Sycume (teprotumumab), the country’s first IGF-1R antibody ...

Sutro Biopharma (Nasdaq: STRO), a US biotechnology company, has announced significant organizational changes, including a ...

Guaranteed success in drug development does not exist, such are the inherent risks, potential pitfalls and costs involved.

Japan’s Shionogi (TYO: 4507) yesterday delivered a late-breaking scientific oral presentation at the Conference of ...